Fed. Circ. Says Teva Can't Block Cenestin Generic
By Leigh Kamping-Carder ( July 21, 2011, 5:05 PM EDT) -- The Federal Circuit on Thursday ruled that Teva Women's Health Inc.'s decision to narrow the claims of a patent for the menopause drug Cenestin doomed its attempt to block Paddock Laboratories Inc. from making a generic version with a different coating....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.